Literature DB >> 33022228

Absence of Survival and Motor Deficits in 500 Repeat C9ORF72 BAC Mice.

Daniel A Mordes1, Brett M Morrison2, Xanthe H Ament2, Christopher Cantrell3, Joanie Mok3, Pierce Eggan3, Carolyn Xue2, Jin-Yuan Wang3, Kevin Eggan4, Jeffrey D Rothstein5.   

Abstract

A hexanucleotide repeat expansion at C9ORF72 is the most common genetic cause of amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD). Initial studies of bacterial artificial chromosome (BAC) transgenic mice harboring this expansion described an absence of motor and survival phenotypes. However, a recent study by Liu and colleagues described transgenic mice harboring a large repeat expansion (C9-500) and reported decreased survival and progressive motor phenotypes. To determine the utility of the C9-500 animals for understanding degenerative mechanisms, we validated and established two independent colonies of transgene carriers. However, extended studies of these animals for up to 1 year revealed no reproducible abnormalities in survival, motor function, or neurodegeneration. Here, we propose several potential explanations for the disparate nature of our findings from those of Liu and colleagues. Resolving the discrepancies we identify will be essential to settle the translational utility of C9-500 mice. This Matters Arising paper is in response to Liu et al. (2016), published in Neuron. See also the response by Nguyen et al. (2020), published in this issue.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALS; C9orf72; FTD; RAN translation; mouse model; neurodegeneration

Mesh:

Substances:

Year:  2020        PMID: 33022228     DOI: 10.1016/j.neuron.2020.08.009

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  11 in total

Review 1.  Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation.

Authors:  Elisa Giacomelli; Björn F Vahsen; Elizabeth L Calder; Yinyan Xu; Jakub Scaber; Elizabeth Gray; Ruxandra Dafinca; Kevin Talbot; Lorenz Studer
Journal:  Cell Stem Cell       Date:  2022-01-06       Impact factor: 24.633

Review 2.  Modelling amyotrophic lateral sclerosis in rodents.

Authors:  Tiffany W Todd; Leonard Petrucelli
Journal:  Nat Rev Neurosci       Date:  2022-03-08       Impact factor: 34.870

3.  Macrophage monocarboxylate transporter 1 promotes peripheral nerve regeneration after injury in mice.

Authors:  Mithilesh Kumar Jha; Joseph V Passero; Atul Rawat; Xanthe Heifetz Ament; Fang Yang; Svetlana Vidensky; Samuel L Collins; Maureen R Horton; Ahmet Hoke; Guy A Rutter; Alban Latremoliere; Jeffrey D Rothstein; Brett M Morrison
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

4.  C9orf72 Hexanucleotide Repeat Expansion-Related Neuropathology Is Attenuated by Nasal Rifampicin in Mice.

Authors:  Yukari Hatanaka; Tomohiro Umeda; Keiko Shigemori; Toshihide Takeuchi; Yoshitaka Nagai; Takami Tomiyama
Journal:  Biomedicines       Date:  2022-05-06

5.  Survival and Motor Phenotypes in FVB C9-500 ALS/FTD BAC Transgenic Mice Reproduced by Multiple Labs.

Authors:  Lien Nguyen; Lauren A Laboissonniere; Shu Guo; Federica Pilotto; Olivier Scheidegger; Angelina Oestmann; Jennetta W Hammond; Herman Li; Anu Hyysalo; Roosa Peltola; Amrutha Pattamatta; Tao Zu; Merja H Voutilainen; Harris A Gelbard; Smita Saxena; Laura P W Ranum
Journal:  Neuron       Date:  2020-10-05       Impact factor: 17.173

6.  Editorial: Primary Glial and Immune Cell Pathology in Neurodegenerative Diseases.

Authors:  András Lakatos; Gabor Petzold
Journal:  Front Neurol       Date:  2021-10-18       Impact factor: 4.003

7.  Phase separation and toxicity of C9orf72 poly(PR) depends on alternate distribution of arginine.

Authors:  Chen Chen; Yoshiaki Yamanaka; Koji Ueda; Peiying Li; Tamami Miyagi; Yuichiro Harada; Sayaka Tezuka; Satoshi Narumi; Masahiro Sugimoto; Masahiko Kuroda; Yuhei Hayamizu; Kohsuke Kanekura
Journal:  J Cell Biol       Date:  2021-09-09       Impact factor: 10.539

Review 8.  Biomarkers for C9orf7-ALS in Symptomatic and Pre-symptomatic Patients: State-of-the-art in the New Era of Clinical Trials.

Authors:  Giorgia Querin; Maria Grazia Biferi; Pierre-Francois Pradat
Journal:  J Neuromuscul Dis       Date:  2022

9.  Selective vulnerability of tripartite synapses in amyotrophic lateral sclerosis.

Authors:  Matthew J Broadhead; Calum Bonthron; Julia Waddington; William V Smith; Maite F Lopez; Sarah Burley; Jessica Valli; Fei Zhu; Noboru H Komiyama; Colin Smith; Seth G N Grant; Gareth B Miles
Journal:  Acta Neuropathol       Date:  2022-03-19       Impact factor: 15.887

Review 10.  Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact.

Authors:  Fabiola De Marchi; Ivana Munitic; Amedeo Amedei; James D Berry; Eva L Feldman; Eleonora Aronica; Giovanni Nardo; Donatienne Van Weehaeghe; Elena Niccolai; Nikolina Prtenjaca; Stacey A Sakowski; Caterina Bendotti; Letizia Mazzini
Journal:  Neurosci Biobehav Rev       Date:  2021-06-19       Impact factor: 9.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.